NZ610474A - Methods to predict clinical outcome of cancer - Google Patents
Methods to predict clinical outcome of cancerInfo
- Publication number
- NZ610474A NZ610474A NZ610474A NZ61047410A NZ610474A NZ 610474 A NZ610474 A NZ 610474A NZ 610474 A NZ610474 A NZ 610474A NZ 61047410 A NZ61047410 A NZ 61047410A NZ 610474 A NZ610474 A NZ 610474A
- Authority
- NZ
- New Zealand
- Prior art keywords
- eno1
- level
- normalised
- clinical outcome
- cancer
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title 1
- 230000014509 gene expression Effects 0.000 abstract 5
- 102100038910 Alpha-enolase Human genes 0.000 abstract 4
- 101000882335 Homo sapiens Alpha-enolase Proteins 0.000 abstract 4
- VLMZMRDOMOGGFA-WDBKCZKBSA-N festuclavine Chemical compound C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C)=C3C2=CNC3=C1 VLMZMRDOMOGGFA-WDBKCZKBSA-N 0.000 abstract 4
- 206010006187 Breast cancer Diseases 0.000 abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract 2
- 101150015836 ENO1 gene Proteins 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26376309P | 2009-11-23 | 2009-11-23 | |
| NZ599194A NZ599194A (en) | 2009-11-23 | 2010-11-19 | Methods to predict clinical outcome of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ610474A true NZ610474A (en) | 2014-09-26 |
Family
ID=51582065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ610474A NZ610474A (en) | 2009-11-23 | 2010-11-19 | Methods to predict clinical outcome of cancer |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ610474A (en) |
-
2010
- 2010-11-19 NZ NZ610474A patent/NZ610474A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ599194A (en) | Methods to predict clinical outcome of cancer | |
| NZ600268A (en) | Method to use gene expression to determine likelihood of clinical outcome of renal cancer | |
| NZ607282A (en) | Method for using gene expression to determine prognosis of prostate cancer | |
| McGrath et al. | Prostate cancer biomarkers: are we hitting the mark? | |
| Wu et al. | Circulating microRNA-21 is a potential diagnostic biomarker in gastric cancer | |
| Xu et al. | Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer | |
| NZ593228A (en) | Gene expression markers (inhba) for colorectal cancer prognosis | |
| WO2014140933A3 (en) | Method for the prognosis and treatment of cancer metastasis | |
| NZ722902A (en) | Gene expression profile algorithm and test for determining prognosis of prostate cancer | |
| WO2013153458A3 (en) | Method for the prognosis and treatment of cancer metastasis | |
| NZ610482A (en) | Predictors of patient response to treatment with egf receptor inhibitors | |
| MX2019000091A (en) | Method for the prognosis and treatment of metastasizing cancer of the bone originating from breast cancer. | |
| GB201009641D0 (en) | Methods of monitoring conditions by sequence analysis | |
| NZ595356A (en) | Methods of predicting cancer risk using gene expression in premalignant tissue | |
| WO2014184679A3 (en) | Method for the prognosis and treatment of renal cell carcinoma metastasis | |
| Wang et al. | Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival. | |
| Li et al. | Circulating microRNA-137 is a potential biomarker for human glioblastoma. | |
| NZ629538A (en) | Targeted rna-seq methods and materials for the diagnosis of prostate cancer | |
| WO2010088688A3 (en) | Diagnosis of in situ and invasive breast cancer | |
| Ivanova et al. | Circulating tumor cells in metastatic breast cancer: from genome instability to metastasis | |
| CN105154447A (en) | Prostatic cancer molecular target AC016745.3 and application thereof to diagnostic kit | |
| WO2017217807A3 (en) | Biomarker comprising nckap1 as effective ingredient for diagnosing colorectal cancer or for predicting metastasis and prognosis of colorectal cancer | |
| Zhou et al. | Increased expression of long non-coding RNA SBDSP1 correlates with poor survival in colorectal cancer | |
| US20190316205A1 (en) | Mmp1 gene transcript for use as a marker for diagnosis of ovarian cancer prognosis, and test method | |
| NZ610474A (en) | Methods to predict clinical outcome of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 19 NOV 2017 BY COMPUTER PACKAGES INC Effective date: 20150120 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 NOV 2018 BY COMPUTER PACKAGES INC Effective date: 20171031 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 NOV 2019 BY COMPUTER PACKAGES INC Effective date: 20181031 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 NOV 2020 BY COMPUTER PACKAGES INC Effective date: 20191031 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 NOV 2021 BY COMPUTER PACKAGES INC Effective date: 20201031 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 NOV 2022 BY COMPUTER PACKAGES INC Effective date: 20211030 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 NOV 2023 BY COMPUTER PACKAGES INC Effective date: 20221030 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 NOV 2024 BY COMPUTER PACKAGES INC Effective date: 20231030 |